Mucopeptides have been defined chemically as those polymers which contain N-acetyl muramic acid, N-acetyl glucosamine, and a characteristic peptide generally composed of D-and L-alanine, D-glutamic acid, either L-lysine or diaminopimelic acid, and in some cases glycine or aspartic acid." 2 These glycopeptides are essential structural components of the cell walls of bacteria and related organisms such as blue-green algae, rickettsia, the psittacosis group of viruses, and the actinomyces (see review3). The mucopeptide of S. aureus H contains a polysaccharide "backbone" composed of N-acetyl muramic acid and N-acetyl glucosamine. Attached to the polysaccharide are ester-linked acetyl groups and a peptide composed of L-alanine, D-glutamic acid, L-lysine, D-alanine, and about 5 glycine residues. There is evidence that considerable cross-linkage occurs between peptide chains.4-6 Such extensive cross-linkage between mucopeptide chains would explain the strength these materials give to the wall.
Nucleotide-bound sugars, which are frequently precursors of simple polysaccharides, have recently been shown to be precursors of more complex polysaccharides as well.7 8 That synthesis of mucopeptide may be similar to polysaccharide synthesis was thus suggested some years ago by the observation that interference with the growth of staphylococci by penicillin led to accumulation within the cells of 3 uridine nucleotides.9 The structure of the largest compound, uridine diphospho-N-acetyl-muramyl-L-alanyl-D-glutamyl-L-lysyl-D-alanyl-D-alanine (UDP-muramyl-peptide) is shown in Figure 1 .9, 10 Since N-acetyl muramic acid and these amino acids are components of the mucopeptide, the 3 uridine compounds have been implicated as precursors of mucopeptide.1'
The composition of the smaller nucleotides suggested that they may be intermediates on a pathway leading to formation of the largest nucleotide-muramyl-peptide.
Indeed, Ito and Strominger'2 have demonstrated that a pathway for the formation of UDP-muramyl-peptide from UDP-N-acetyl muramic acid exists in staphylococci. The alternate transfer of muramyl-peptide and N-acetyl glucosamine from their respective uridine nucleotides to an acceptor mucopeptide would thus make the initial polymerization of mucopeptide "backbone" comparable to synthesis of polysaccharide. Subsequent addition of glycine to the polymer and the introduc- Materials and Methods.-Preparation of radioactive UDP-muramyl-peptide: A washed suspension of log phase cells of S. aureus (cell density ca. 1.5 mg dry wt/ml) was shaken vigorously for 90 min at 370 in the presence of vancomycin (20 ,ug/ml) in a medium (pH 6.8) composed of 10-3 M glycine, 10-3 M L-glutamic acid, 5 X 10-4 M L-alanine, 2 X 10-4 M L-lysine, 10-3 M MgCl2, 10-4 M MnCl2, 1.7 X 10-4 M uracil, 3 X 10-6 M thiamine, 8 .2 X 10 6 M nicotinamide, 2.85 X 10-2 M glucose, and 8 X 10-2 M K2HPO4. The cells were then harvested by centrifugation, washed, and extracted three times with cold 0.3 N HC104. The extract was neutralized with KOH, the insoluble KC104 removed, and the extract applied to a Dowex-l-formate column (200-400 mesh). A gradient elution with ammonium formate-formic acid13 was employed, and the fractions containing the labeled UDP-muramyl-peptide were combined and lyophilized. The final product was identified as UDP-muramyl-peptide by paper chromatography and electrophoresis. For preparation of substrate labeled in the amino acid, C14-L-lysine or H3-DL-glutamate was used. The pyrimidine moiety was labeled by adding uracil-2-C'4 to the incubation medium. The final specific activities (assuming no dilution from the cellular pool) were 3 X 103 cpm/m/Lmole for the UDP-muramyl-peptide labeled in lysine or glutamate and 6.6 X 103 cpm/ m/umole when the label was in the uracil moiety.
Preparation of crude particulate fraction: Staphylococcus aureus strain H was grown at 370 with aeration to a cell density of 0.3-0.4 mg (dry wt) per ml in a medium composed of 5 gm peptone, 5 gm yeast extract, 3 gm K2HPO4, and 2 gm glucose, pH 7.2. The glucose was sterilized separately. The cells were disrupted by shaking 7 ml of a 3% suspension of cells in 0.05 M tris-HCl buffer, pH 8, with an equal volume of acid-washed Ballotini no. 12 glass beads for 10-15 minutes in a Mickle disintegrator. To obtain the crude particulate fraction, the extract, after removal of unbroken cells and cell walls, was centrifuged at 105,000 X g for 45 min. The light yellow translucent pellet obtained from 300 mg of cells was resuspended with the aid of an homogenizer in 2-4 ml of 0.02 M tris-HCl buffer, pH 8.0 containing 0.01 M MgCl2 and 0.001 M mercaptoethanol. This suspension represents the crude particulate fraction used in the initial studies of mucopeptide synthesis. Procedures for fractionation of the synthesizing system are described under Results.
Assay of activity: In a typical experiment, radioactive substrates and other needed components in 0.2 ml 0.01 M tris-HCl, pH 8, were incubated at 370 with 1 mg of the particulate fraction for 10 min. The reaction was stopped by addition of 4 ml of cold 0.3 M HC104. The insoluble residue was sedimented by centrifugation at 8,000 X g for 5 min and washed twice with 4 ml of 0.3 M HC104. The sediment was then transferred with the aid of 1 ml of water to bottles containing 20 ml of a mixture consisting of 400 gm naphthalene, 14 gm 2,5 diphenyloxazole (PPO), 0.6 gm p-bis-2-(5 phenyloxazolyl)-1-benzene (POPOP), and 1,930 ml of dioxane and counted for 20 min in a liquid scintillation counter (Nuclear-Chicago). Results.- Table 1 shows the activity of various cell fractions that incorporate radioactivity from added UDP-muramyl-(C14-lysine)-peptide. As can be seen, the particulate fraction, composed of membrane material and ribosomes, contained the bulk of the activity, whereas intact cells were unable to utilize the nucleotidebound peptide. Conversely, though intact cells incorporated free lysine readily, the particulate fraction incorporated free H3-lysine at one eighth the rate of incorporation of C14 from UDP-muramyl-(C'4-lysine)-peptide. The incorporation of C14 is believed to be a measure of muramyl-peptide transferred from UDPmuramyl-(C'4-lysine)-peptide. These data suggest that the nucleotide-bound muramyl-peptide is a mucopeptide precursor and that the activity of the particulate fraction is not due to the presence of intact cells. The particulate fraction used in most of this work contained membrane material (30-40%) and ribosomes (60- frozen for two weeks or repeatedly thawed and refrozen without appreciable loss of activity. The amount of incorporation of C'4-lysine from UDP-muramyl-(C14-lysine)-peptide in 10 min was proportional to the concentration of particulate fraction up to about 20 mg dry wt/ml. The rate of incorporation of label from UDP-muramyl-(C14-lysine)-peptide was maximal in the pH range 8.0-8.2. Therefore, the pH of the incorporation system was maintained at 8.0 unless otherwise stated.
The requirements for maximum incorporation are shown in Table 2 . As shown, maximum incorporation was dependent on UDPAG and Mg and to a lesser extent on ATP, but was not dependent on glycine or KC1. The incorporation of glycine (another component of S. aureus mucopeptide) was dependent on both UDPAG and UDP-muramyl-(C 4-lysine)-peptide. Glycine incorporation showed a more marked stimulation by ATP and was stimulated by KCl and Mg. Manganese did not replace Mg at equivalent concentration for either incorporation. Chloramphenicol was present in the incubation mixture to prevent incorporation of glycine into protein, but omission of chloramphenicol did not greatly increase the amount of incorporation. As will be shown later, the properties of the product are consistent with the view that glycine is being incorporated into mucopeptide rather than into protein. The pH optimum for glycine incorporation was also about 8.0. The system for glycine incorporation was found to be more unstable than that for incorporation of muramyl-peptide. The rate of incorporation of glycine also leveled off rapidly with time as shown in Figure 1 . Radioactivity from UDP-muramyl-(H3-glutamate)-peptide was also found to be incorporated by the enzyme. This incorporation had the same characteristics as that described for UDP-muramyl-(C'4-lysine)-peptide, i.e., stimulation by UDPAG and ATP. We also used UDP-muramyl-peptide labeled in the uracil moiety. The results are shown in Table 3 : experiment 1 shows that C14 from UDP-muramylpeptide (C14-uracil) was poorly incorporated; experiment 2 shows that the uracillabeled UDP-muramyl-peptide was in fact UDP-muramyl-peptide, since it stimulated incorporation of glycine as effectively as authentic Cl2-UDP-muramyl- peptide. Since label from UDP-muramyl-peptide labeled with glutamate or lysine was incorporated but label from (Cl4-uracil)-UDP-muramyl-peptide was not, it is likely that the incorporation of label indicates incorporation of the muramyl-peptide fragment as a unit. The particulate material was further fractionated by differential centrifugation to obtain "membrane particles" and ribosomes. As can be seen from Table 4 , the "membrane particles," the ribosomes, and a soluble nondialyzable material in the cell extract were needed for maximum incorporation of glycine. The soluble material was not inactivated by heating at 1000 for 10 min. RNAase added to the incubation mixture destroyed its ability to incorporate glycine but did not interfere with the incorporation of C14 from UDP-muramyl-(C14-lysine)-peptide.
The specificity of the system for UDP-muramyl-peptide is shown in Table 5 . The incorporation of glycine was reduced almost 75 per cent by omitting UDPmuramyl-peptide. UDP-N-acetyl muramic acid and UDP-N-acetyl muramyl-Lalanine (two other nucleotides normally present in S. aureus H) did not substitute for UDP-muramyl-peptide. This strongly suggests that UDP-muramyl-peptide is specifically required for mucopeptide synthesis and that the other nucleotide-bound muramic acid derivatives are merely precursors.
Effect of cell wall fractions as primers for the reaction: Attempts were made to demonstrate a requirement for an exogenous acceptor or a primer in the above system. Addition of S. aureus cell walls or fractions of wall made soluble by alkali or autolysis had no effect on the incorporation system. It is likely that mucopeptide present in the particulate enzyme fraction served as acceptor.
Characterization of products: Only a few mntimoles of product have been prepared for study. Consequently, indirect methods were used in order to compare it with mucopeptide. Paper chromatography after acid hydrolysis demonstrated that the C14-lysine and H3-glycine were incorporated as such and had not undergone conversion to other compounds. The product was extractable with hot acid. In a typical experiment 70 per cent of the radioactive product extracted with hot acid was nondialyzable, and the remainder was readily separable from H3-glycine on Sephadex G25. The nondialyzable material was treated in various ways as shown in Table 6 and redialyzed to determine the extent of breakdown caused by the various treatments. As can be seen, trypsin, RNAase, and alkali did not break down this product. Since the product was soluble in hot acid and was not made dialyzable by trypsin, it is not protein in nature. Since the radioactivity was not rendered dialyzable by the action of RNAase or alkali, it was not present as activated amino acids on transfer RNA. Resistance to all these treatments is characteristic of mucopeptide. Even though lysozyme attacks mucopeptide, it apparently does not release dialyzable peptides because of cross-linkage between peptides.6 Hence, the test with lysozyme may indicate considerable cross-linkage.
Effect of antibiotics: Antibiotics known to interfere with mucopeptide synthesis in intact staphylococci, namely, penicillin, 16a, 16b vancomycin,'4' '-and bacitracin, 16a, i6b
did not interfere with mucopeptide synthesis by this cell-free system. However, as shown in Table 7 , the particulate fraction from staphylococci grown in the presence of any of these antibiotics for 20 min lost much of its ability to utilize UDP-muramyl-(C'4-lysine)-peptide, although it still could incorporate glycine. In a separate study we investigated the relationship between the irreversible binding of penicillin to cells and their inability to synthesize mucopeptide. It was found that treatment with antibiotic must occur while the cells are growing rapidly in order to be effective.'7 Thus, the conditions for inactivation of the cell-free system are comparable to those for intact cells. "Membrane particles" from cells grown in the presence of chloramphenicol or tetracycline also incorporate C14 from UDPmuramyl(C'4-lysine)-peptide at a reduced rate. This will be considered below.
Discussion.-We believe that the incorporation of amino acids observed in this crude system is a reflection of the synthesis of the backbone polysaccharide of mnucopeptide from UDPAG and UDP-muramyl-(C'4-lysine)-peptide by transfer of AG and muramyl-peptide to an acceptor; this is followed by addition of a small glycine peptide to the newly formed polymer. The polymerization reaction is mediated by a particulate fraction that is sedimented in 20 min at 39,000 x g. This particulate fraction is referred to as "membrane particles" to indicate its principal component. The polymerization reaction requires magnesium and is stimulated by ATP. It is insensitive to ribonuclease. The incorporation of glycine is stimulated by ribosomes, KC1, and a nondialyzable, heat-stable fraction of cell sap, as well as by the components of the complete system for the polymerization reaction. Since the incorporation of glycine is greatly reduced or in fact often prevented by the presence of ribonuclease, and since ribosomes and KCl stimulate incorporation, part of the system resembles the protein-synthesizing system of bacteria. It has been suggested that the glycine of S. aureus mucopeptide may be present as a polyglycine of 5 or 6 residues which serves as a cross-linking bridge between adjacent muramyl-peptide units.6 If a polymer of 5 or 6 residues requires messenger RNA and ribosomes for its formation, the situation would be analogous to protein synthesis. The addition of the polyglycine to the mucopeptide would then be a single reaction requiring newly formed mucopeptide backbone (i.e., mucopeptide lacking glycine) as acceptor. Hence, the role of UDPAG and UDP-muramyl-(C'4-lysine)-peptide would be to permit synthesis of this acceptor. The ratio of the amount of glycine to lysine incorporated has been variable, from as little as 1: 1 to more than 10: 1. This variation may be a reflection of the amount of active glycine-incorporating components present. The dependence of the glycine-incorporating activity upon UDP-muramyl-(C'4-lysine)-peptide rather than UDP-muramyl-L-alanine shows a remarkable specificity. It is this dependence that leads us to believe that glycine is being incorporated into mucopeptide in this system. The stability characteristics of the product formed support this view.
The antibiotics-penicillin, vancomycin, and bacitracin-are believed to inhibit mucopeptide synthesis in whole cells by interfering with the polymerization reaction. Nevertheless, the antibiotics had no effect when added directly to the cellfree system. On the other hand, the particulate enzyme obtained from cells which had grown in the presence of antibiotic for 20 min showed specific damage. These particles were inhibited 84-97 per cent in their ability to utilize UDP-muramyl-(C'4-lysine)-peptide, whereas they could utilize glycine normally. This is a very peculiar phenomenon. It suggests to us that the polymerization reaction was specifically inactivated and that a small amount of incomplete mucopeptide was available to accept glycine. The fact that inactivation of the system occurred only under growth conditions may be related to the fact that penicillin kills only growing bacteria,18 and it may indicate that the sensitive enzyme is only available to react with antibiotics while the cells are actively growing. Inactivation of the ability of intact cells to synthesize mucopeptide by pretreatment with penicillin, vancomycin, or bacitracin also occurs only under growth conditions. '7 The particulate fraction from cells pretreated with chloramphenicol (which specifically inhibits protein synthesis while mucopeptide synthesis seemingly continues in whole cells) 19' 20 can utilize neither glycine nor UDP-muramyl-(C'4-lysine)-peptide at a normal rate. This unexpected result leads us to speculate that only newly synthesized polymerizing enzyme participates in mucopeptide synthesis. Cole and Hahn have shown that cell wall synthesis is restricted to a narrow equatorial region in Streptococcus pyogenes.2' If staphylococci are similar, then polymerizing enzyme fixed to the membrane would be physically at the site of synthesis of wall for a limited period of time. Thus, in effect, growth in the presence of chloramphenicol would have depleted the site of polymerizing enzyme because no new enzyme was formed and the site of synthesis moved as mucopeptide synthesis proceeded.
As this report shows, we have demonstrated only stimulatory effects rather than absolute requirements. We have not made extensive attempts to free the "membrane particles" or ribosomes of substrates, primers, or cofactors. It is quite likely that the "membrane particles" fraction is contaminated with ribosomes and vice versa. Work is under way to resolve the components of the system.
